3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
35
Carcinoma, Non-Small-Cell Lung
27
Lung Neoplasms
26
Neoplasms
16
Uterine Cervical Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Esophageal Neoplasms
10
Sarcoma
9
Rectal Neoplasms
9
Carcinoma, Renal Cell
9
Carcinoma, Hepatocellular
9
Prostatic Neoplasms
8
Neoplasm Metastasis
8
Lymphoma
8
Brain Neoplasms
8
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Oropharyngeal Neoplasms
7
Multiple Myeloma
7
Melanoma
7
Head and Neck Neoplasms
7
Glioblastoma
7
Colorectal Neoplasms
7
Urinary Bladder Neoplasms
6
Thyroid Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Hodgkin Disease
6
Colonic Neoplasms
6
Salivary Gland Neoplasms
5
Ovarian Neoplasms
5
Interventions
Fluorodeoxyglucose F18
1
Cytoreduction Surgical Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cytoreductive Surgery
×
Fluorodeoxyglucose F18
×
Clear all
NCT05390021
2024-04-02
PET/MRI in Endometrial Cancer
Massachusetts General Hospital
Phase NA
Withdrawn